CLINICAL_TRIALS
trial_result
· 2016-10-25
Clinical Trial Update: Compare S-1 Plus Oxaliplatin to S-1 as Adjuvant Chemotherapy After D2 Resection in Patients With Gastric Cancer [Phase 3]
Summary
A Phase 3 trial comparing S-1 plus oxaliplatin versus S-1 alone as adjuvant chemotherapy after D2 gastrectomy for gastric cancer.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sun Yat-sen University | Conditions: Gastric Cancer | Phase 3 | Status: UNKNOWN